Riskpilot← Back to searchSign inGet full accessGYN-PRO Aktiebolag
ABActiveOrg 5563779643Näsbydalsvägen 6 Lgh 2501General medical practice activities · NACE 8621Est. 19891 employees
Revenue 2025
—
EBITDA margin
—
-463% vs 2024
Equity ratio
48.4%
Financial strength
Net profit 2025
SEK -23K
-875% vs 2024
| Revenue | — | — |
| EBITDA | SEK -25K | -463% |
| Net profit | SEK -23K | -875% |
| Total assets | SEK 442K | -5% |
| Equity | SEK 214K | -10% |
| Employees | 1 | — |
Legal name
GYN-PRO Aktiebolag
Org number
5563779643
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 december 1989
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarverksamhet, klinisk forskning och ekonomisk rådgivning samt därmed förnelig verksamhet.
Address
Näsbydalsvägen 6 Lgh 2501
Email
marie-louise.metzger@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | — | 27 | — |
| Staff expenses | — | −8 | −6 | −7 | −0 |
| EBITDA | −31 | −35 | −24 | −4 | −25 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −31 | −35 | −24 | −4 | −25 |
| Net financials | — | 1 | 8 | 7 | 1 |
| Profit before tax | −31 | −34 | −16 | 3 | −23 |
| Tax | −0 | — | — | — | — |
| Net profit | −31 | −34 | −16 | 3 | −23 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 474 | 466 | 450 | 464 | 442 |
| Equity | 284 | 250 | 234 | 237 | 214 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 190 | 216 | 216 | 227 | 228 |
| Total debt | 190 | 216 | 216 | 227 | 228 |
EBITDA margin
-2459500.0%
This company
15.8%
Market median
-15566556% vs market
20212025
Equity ratio
48.4%
This company
38.2%
Market median
+27% vs market
20212025
Return on equity
-10.9%
This company
18.4%
Market median
-159% vs market
20212025
Net profit margin
-2327000.0%
This company
8.1%
Market median
-28728495% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GYN-PRO Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dagny Marie-Louise Metzger | Board of Directors | 0 companies |
| Werner Alfred Metzger | Deputy Board Member | 0 companies |
| Jonas Andreas Metzger | Deputy Board Member | 0 companies |